HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.

Abstract
Serotonin (5-hydroxytryptamine; 5-HT) transporters (SERTs) are critical determinants of synaptic 5-HT inactivation and the targets for multiple drugs used to treat psychiatric disorders. In support of prior studies, we found that short-term (5-30 min) application of the adenosine receptor (AR) agonist 5'-N-ethylcarboxamidoadenosine (NECA) induces an increase in 5-HT uptake Vmax in rat basophilic leukemia 2H3 cells that is enhanced by pretreatment with the cGMP phosphodiesterase inhibitor sildenafil. NECA stimulation is blocked by the A3 AR antagonist 3-ethyl-5-benzyl-2-methyl-phenylethynyl-6-phenyl-1,4(+/-)dihydropyridine-3,5-dicarboxylate (MRS1191), by the phospholipase C inhibitor 1-(6-[[17beta-3-methoxyestra-1,3,5(10)-trien-17-yl] amino]hexyl)-1H-pyrrole-2,5-dione (U73122), by the intracellular Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester, and by the guanyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Hydroxylamine, a nitric-oxide donor, and 8-bromo-cGMP, a membrane-permeant analog of cGMP, mimic the effects of NECA on 5-HT uptake, whereas the protein kinase G (PKG) inhibitor N-[2-(methylamino)ethy]-5-isoquinoline-sulfonamide (H8) blocks NECA, hydroxylamine, and 8-bromo-cGMP effects. NECA stimulation activates p38 mitogen-activated protein kinase (MAPK), whereas p38 MAPK inhibitors block NECA stimulation of SERT activity, as does the protein phosphatase 2A (PP2A) inhibitor calyculin A. 5-HT-displaceable [125I]3beta-(4-iodophenyl)-tropane-2beta-carboxylic acid methylester tartrate (RTI-55) whole-cell binding is increased by NECA or sildenafil, and both surface binding and cell surface SERT protein are elevated after NECA or sildenafil stimulation of AR/SERT-cotransfected Chinese hamster ovary cells. Whereas p38 MAPK inhibition blocks NECA stimulation of 5-HT activity, it fails to blunt stimulation of SERT surface density. Moreover, inactivation of existing surface SERTs fails to eliminate NECA stimulation of SERT. Together, these results reveal two PKG-dependent pathways supporting rapid SERT regulation by A3 ARs, one leading to enhanced SERT surface trafficking, and a separate, p38 MAPK-dependent process augmenting SERT intrinsic activity.
AuthorsChong-Bin Zhu, William A Hewlett, Igor Feoktistov, Italo Biaggioni, Randy D Blakely
JournalMolecular pharmacology (Mol Pharmacol) Vol. 65 Issue 6 Pg. 1462-74 (Jun 2004) ISSN: 0026-895X [Print] United States
PMID15155839 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carrier Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Receptors, Purinergic P1
  • Serotonin Plasma Membrane Transport Proteins
  • Slc6a4 protein, rat
  • Sulfones
  • Serotonin
  • Adenosine-5'-(N-ethylcarboxamide)
  • Sildenafil Citrate
  • Cyclic GMP-Dependent Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Type C Phospholipases
  • Guanylate Cyclase
  • Cyclic GMP
  • Calcium
Topics
  • Adenosine-5'-(N-ethylcarboxamide) (pharmacology)
  • Animals
  • Biological Transport
  • CHO Cells
  • Calcium (metabolism)
  • Carrier Proteins (metabolism)
  • Cells, Cultured
  • Cricetinae
  • Cyclic GMP (metabolism)
  • Cyclic GMP-Dependent Protein Kinases (physiology)
  • Female
  • Guanylate Cyclase (metabolism)
  • Membrane Glycoproteins (metabolism)
  • Membrane Transport Proteins
  • Mitogen-Activated Protein Kinases (physiology)
  • Nerve Tissue Proteins (metabolism)
  • Phosphodiesterase Inhibitors (pharmacology)
  • Piperazines (pharmacology)
  • Purines
  • Rats
  • Receptors, Purinergic P1 (physiology)
  • Serotonin (metabolism)
  • Serotonin Plasma Membrane Transport Proteins
  • Sildenafil Citrate
  • Sulfones
  • Type C Phospholipases (metabolism)
  • Up-Regulation
  • p38 Mitogen-Activated Protein Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: